A 0 1 0 1 O
serious 2 9 2 9 O
, 9 10 9 10 O
concomitant 11 22 11 22 O
disorder 23 31 23 31 O
, 31 32 31 32 O
including 33 42 33 42 O
active 43 49 43 49 O
systemic 50 58 50 58 B-chronic_disease
infection 59 68 59 68 I-chronic_disease
requiring 69 78 69 78 O
treatment 79 88 79 88 B-treatment

Active 0 6 89 95 O
genital 7 14 96 103 B-chronic_disease
ulcers 15 21 104 110 I-chronic_disease

Any 0 3 111 114 O
known 4 9 115 120 O
allergy 10 17 121 128 O
or 18 20 129 131 O
hypersensitivity 21 37 132 148 O
to 38 40 149 151 O
vaginal 41 48 152 159 B-allergy_name
lubricants 49 59 160 170 I-allergy_name
or 60 62 171 173 O
any 63 66 174 177 O
component 67 76 178 187 O
of 77 79 188 190 O
study 80 85 191 196 O
product 86 93 197 204 O

Any 0 3 205 208 O
previous 4 12 209 217 B-treatment
surgical 13 21 218 226 I-treatment
excision 22 30 227 235 I-treatment
of 31 33 236 238 O
cervical 34 42 239 247 B-cancer
intraepithelial 43 58 248 263 I-cancer
neoplasia 59 68 264 273 I-cancer
( 69 70 274 275 I-cancer
CIN 70 73 275 278 I-cancer
) 73 74 278 279 I-cancer
or 75 77 280 282 O
hysterectomy 78 90 283 295 B-treatment

Any 0 3 296 299 O
significant 4 15 300 311 O
cardiac 16 23 312 319 B-chronic_disease
, 23 24 319 320 O
hepatic 25 32 321 328 B-chronic_disease
or 33 35 329 331 O
renal 36 41 332 337 B-chronic_disease
disease 42 49 338 345 I-chronic_disease

Documented 0 10 346 356 O
human 11 16 357 362 B-chronic_disease
immunodeficiency 17 33 363 379 I-chronic_disease
virus 34 39 380 385 I-chronic_disease
( 40 41 386 387 I-chronic_disease
HIV 41 44 387 390 I-chronic_disease
) 44 45 390 391 I-chronic_disease
infection 46 55 392 401 I-chronic_disease
, 55 56 401 402 O
genital 57 64 403 410 B-chronic_disease
warts 65 70 411 416 I-chronic_disease
, 70 71 416 417 O
chancroid 72 81 418 427 B-chronic_disease
, 81 82 427 428 O
or 83 85 429 431 O
pelvic 86 92 432 438 B-chronic_disease
inflammatory 93 105 439 451 I-chronic_disease
disease 106 113 452 459 I-chronic_disease
that 114 118 460 464 O
will 119 123 465 469 O
require 124 131 470 477 O
long 132 136 478 482 O
term 137 141 483 487 O
treatment 142 151 488 497 B-treatment

Documented 0 10 498 508 O
or 11 13 509 511 O
suspected 14 23 512 521 O
immunosuppressive 24 41 522 539 B-chronic_disease
disorder 42 50 540 548 I-chronic_disease
or 51 53 549 551 O
autoimmune 54 64 552 562 B-chronic_disease
disease 65 72 563 570 I-chronic_disease

Engaging 0 8 571 579 O
in 9 11 580 582 O
three 12 17 583 588 O
or 18 20 589 591 O
more 21 25 592 596 O
intercourse 26 37 597 608 O
events 38 44 609 615 O
( 45 46 616 617 O
defined 46 53 617 624 O
as 54 56 625 627 O
having 57 63 628 634 O
penile 64 70 635 641 O
- 70 71 641 642 O
vaginal 71 78 642 649 O
intercourse 79 90 650 661 O
) 90 91 661 662 O
per 92 95 663 666 O
month 96 101 667 672 O
; 101 102 672 673 O
subjects 103 111 674 682 O
must 112 116 683 687 O
consent 117 124 688 695 O
not 125 128 696 699 O
to 129 131 700 702 O
douche 132 138 703 709 O
or 139 141 710 712 O
use 142 145 713 716 O
any 146 149 717 720 O
vaginal 150 157 721 728 O
products 158 166 729 737 O
, 166 167 737 738 O
including 168 177 739 748 O
tampons 178 185 749 756 O
, 185 186 756 757 O
for 187 190 758 761 O
24 191 193 762 764 B-upper_bound
hours 194 199 765 770 I-upper_bound
before 200 206 771 777 I-upper_bound
enrollment 207 217 778 788 O
and 218 221 789 792 O
study 222 227 793 798 O
visits 228 234 799 805 O

Intranasal 0 10 806 816 B-treatment
, 10 11 816 817 I-treatment
inhaled 12 19 818 825 I-treatment
and/or 20 26 826 832 I-treatment
topical 27 34 833 840 I-treatment
steroids 35 43 841 849 I-treatment
are 44 47 850 853 O
permissible 48 59 854 865 O

Normal 0 6 866 872 B-cancer
Pap 7 10 873 876 I-cancer
or 11 13 877 879 I-cancer
Atypical 14 22 880 888 I-cancer
Squamous 23 31 889 897 I-cancer
Cells 32 37 898 903 I-cancer
of 38 40 904 906 I-cancer
Undetermined 41 53 907 919 I-cancer
Significance 54 66 920 932 I-cancer
( 67 68 933 934 I-cancer
ASCUS 68 73 934 939 I-cancer
) 73 74 939 940 I-cancer
Pap 75 78 941 944 O
test 79 83 945 949 O
with 84 88 950 954 O
HPV 89 92 955 958 B-chronic_disease
deoxyribonucleic 93 109 959 975 I-chronic_disease
acid 110 114 976 980 I-chronic_disease
( 115 116 981 982 I-chronic_disease
DNA 116 119 982 985 I-chronic_disease
) 119 120 985 986 O
negative 121 129 987 995 O
by 130 132 996 998 O
reflex 133 139 999 1005 O
testing 140 147 1006 1013 O
via 148 151 1014 1017 O
Hybrid 152 158 1018 1024 O
Capture 159 166 1025 1032 O
2 167 168 1033 1034 O
( 169 170 1035 1036 O
Digene 170 176 1036 1042 O
Corp. 177 182 1043 1048 O
, 182 183 1048 1049 O
Gaithersburg 184 196 1050 1062 O
, 196 197 1062 1063 O
MD 198 200 1064 1066 O
) 200 201 1066 1067 O
, 201 202 1067 1068 O
a 203 204 1069 1070 O
standard 205 213 1071 1079 B-treatment
clinical 214 222 1080 1088 I-treatment
assay 223 228 1089 1094 I-treatment
within 229 235 1095 1101 O
clinically 236 246 1102 1112 O
acceptable 247 257 1113 1123 O
screening 258 267 1124 1133 O
guidelines 268 278 1134 1144 O
( 279 280 1145 1146 O
American 280 288 1146 1154 O
Cancer 289 295 1155 1161 O
Society 296 303 1162 1169 O
[ 304 305 1170 1171 O
ACS]/American 305 318 1171 1184 O
Society 319 326 1185 1192 O
for 327 330 1193 1196 O
Colposcopy 331 341 1197 1207 O
and 342 345 1208 1211 O
Cervical 346 354 1212 1220 O
Pathology 355 364 1221 1230 O
[ 365 366 1231 1232 O
ASCCP 366 371 1232 1237 O
] 371 372 1237 1238 O
2012 373 377 1239 1243 O
Screening 378 387 1244 1253 O
Guidelines 388 398 1254 1264 O
) 398 399 1264 1265 O

Pregnant 0 8 1266 1274 B-pregnancy
and/or 9 15 1275 1281 O
breast 16 22 1282 1288 O
- 22 23 1288 1289 O
feeding 23 30 1289 1296 O

Prior 0 5 1297 1302 O
history 6 13 1303 1310 O
of 14 16 1311 1313 O
or 17 19 1314 1316 O
current 20 27 1317 1324 O
malignancy 28 38 1325 1335 B-cancer
other 39 44 1336 1341 O
than 45 49 1342 1346 O
adequately 50 60 1347 1357 O
treated 61 68 1358 1365 O
skin 69 73 1366 1370 B-cancer
cancer 74 80 1371 1377 I-cancer
( 81 82 1378 1379 O
squamous 82 90 1379 1387 B-cancer
cell 91 95 1388 1392 I-cancer
cancer 96 102 1393 1399 I-cancer
or 103 105 1400 1402 O
basal 106 111 1403 1408 B-cancer
cell 112 116 1409 1413 I-cancer
carcinoma 117 126 1414 1423 I-cancer
) 126 127 1423 1424 O

Prior 0 5 1425 1430 O
use 6 9 1431 1434 O
of 10 12 1435 1437 O
an 13 15 1438 1440 O
HPV 16 19 1441 1444 B-treatment
vaccine 20 27 1445 1452 I-treatment

Recent 0 6 1453 1459 O
( 7 8 1460 1461 O
within 8 14 1461 1467 O
4 15 16 1468 1469 O
weeks 17 22 1470 1475 O
of 23 25 1476 1478 O
screening 26 35 1479 1488 O
) 35 36 1488 1489 O
or 37 39 1490 1492 O
concomitant 40 51 1493 1504 O
long 52 56 1505 1509 O
term 57 61 1510 1514 O
treatment 62 71 1515 1524 B-treatment
with 72 76 1525 1529 O
systemic 77 85 1530 1538 B-treatment
steroids 86 94 1539 1547 I-treatment
, 94 95 1547 1548 O
immunosuppressive 96 113 1549 1566 B-treatment
/ 113 114 1566 1567 I-treatment
immunomodulating 114 130 1567 1583 I-treatment
drugs 131 136 1584 1589 I-treatment
( 137 138 1590 1591 O
e.g. 138 142 1591 1595 O
cyclosporine 143 155 1596 1608 B-treatment
, 155 156 1608 1609 O
corticosteroids 157 172 1610 1625 B-treatment
) 172 173 1625 1626 O

Sexually 0 8 1627 1635 O
active 9 15 1636 1642 O
women 16 21 1643 1648 B-gender
of 22 24 1649 1651 O
all 25 28 1652 1655 O
ethnicities 29 40 1656 1667 O
and 41 44 1668 1671 O
races 45 50 1672 1677 O
with 51 55 1678 1682 O
an 56 58 1683 1685 O
intact 59 65 1686 1692 O
cervix 66 72 1693 1699 O
are 73 76 1700 1703 O
eligible 77 85 1704 1712 O
for 86 89 1713 1716 O
this 90 94 1717 1721 O
trial 95 100 1722 1727 O

Speaks 0 6 1728 1734 B-language_fluency
either 7 13 1735 1741 I-language_fluency
English 14 21 1742 1749 I-language_fluency
or 22 24 1750 1752 I-language_fluency
Spanish 25 32 1753 1760 I-language_fluency
, 32 33 1760 1761 O
living 34 40 1762 1768 O
in 41 43 1769 1771 O
or 44 46 1772 1774 O
near 47 51 1775 1779 O
Newark 52 58 1780 1786 O
with 59 63 1787 1791 O
no 64 66 1792 1794 O
plans 67 72 1795 1800 O
to 73 75 1801 1803 O
move 76 80 1804 1808 O
in 81 83 1809 1811 O
the 84 87 1812 1815 O
next 88 92 1816 1820 O
year 93 97 1821 1825 O
, 97 98 1825 1826 O
able 99 103 1827 1831 O
to 104 106 1832 1834 O
sign 107 111 1835 1839 O
consent 112 119 1840 1847 O
and 120 123 1848 1851 O
complete 124 132 1852 1860 O
questionnaires 133 147 1861 1875 O
with 148 152 1876 1880 O
aid 153 156 1881 1884 O
of 157 159 1885 1887 O
trained 160 167 1888 1895 O
personnel 168 177 1896 1905 O

Use 0 3 1906 1909 O
of 4 6 1910 1912 O
an 7 9 1913 1915 O
investigational 10 25 1916 1931 B-treatment
drug 26 30 1932 1936 I-treatment
in 31 33 1937 1939 O
the 34 37 1940 1943 O
3 38 39 1944 1945 B-upper_bound
months 40 46 1946 1952 I-upper_bound
prior 47 52 1953 1958 I-upper_bound
to 53 55 1959 1961 O
screening 56 65 1962 1971 O
and 66 69 1972 1975 O
must 70 74 1976 1980 O
agree 75 80 1981 1986 O
to 81 83 1987 1989 O
not 84 87 1990 1993 O
participate 88 99 1994 2005 O
in 100 102 2006 2008 O
any 103 106 2009 2012 O
drug 107 111 2013 2017 O
or 112 114 2018 2020 O
device 115 121 2021 2027 O
study 122 127 2028 2033 O
while 128 133 2034 2039 O
enrolled 134 142 2040 2048 O
in 143 145 2049 2051 O
this 146 150 2052 2056 O
study 151 156 2057 2062 O

Using 0 5 2063 2068 O
an 6 8 2069 2071 O
adequate 9 17 2072 2080 O
method 18 24 2081 2087 O
of 25 27 2088 2090 O
contraception 28 41 2091 2104 O
for 42 45 2105 2108 O
at 46 48 2109 2111 O
least 49 54 2112 2117 O
3 55 56 2118 2119 B-lower_bound
months 57 63 2120 2126 I-lower_bound
with 64 68 2127 2131 O
no 69 71 2132 2134 O
changes 72 79 2135 2142 O
and 80 83 2143 2146 O
will 84 88 2147 2151 O
remain 89 95 2152 2158 O
on 96 98 2159 2161 O
the 99 102 2162 2165 O
contraception 103 116 2166 2179 O
for 117 120 2180 2183 O
the 121 124 2184 2187 O
duration 125 133 2188 2196 O
of 134 136 2197 2199 O
the 137 140 2200 2203 O
trial 141 146 2204 2209 O
; 146 147 2209 2210 O
an 148 150 2211 2213 O
adequate 151 159 2214 2222 O
method 160 166 2223 2229 O
of 167 169 2230 2232 O
contraception 170 183 2233 2246 O
is 184 186 2247 2249 O
defined 187 194 2250 2257 O
as 195 197 2258 2260 O
either 198 204 2261 2267 O
a 205 206 2268 2269 O
hormonal 207 215 2270 2278 O
based 216 221 2279 2284 O
method 222 228 2285 2291 O
( 229 230 2292 2293 O
except 230 236 2293 2299 O
vaginal 237 244 2300 2307 O
rings 245 250 2308 2313 O
) 250 251 2313 2314 O
; 251 252 2314 2315 O
an 253 255 2316 2318 O
intrauterine 256 268 2319 2331 B-contraception_consent
device 269 275 2332 2338 I-contraception_consent
( 276 277 2339 2340 I-contraception_consent
IUD 277 280 2340 2343 I-contraception_consent
) 280 281 2343 2344 I-contraception_consent
( 282 283 2345 2346 O
inserted 283 291 2346 2354 O
at 292 294 2355 2357 O
least 295 300 2358 2363 O
30 301 303 2364 2366 B-lower_bound
days 304 308 2367 2371 I-lower_bound
prior 309 314 2372 2377 I-lower_bound
to 315 317 2378 2380 O
enrollment 318 328 2381 2391 O
) 328 329 2391 2392 O
; 329 330 2392 2393 O
female 331 337 2394 2400 B-gender
sterilization 338 351 2401 2414 O
; 351 352 2414 2415 O
or 353 355 2416 2418 O
sexual 356 362 2419 2425 O
activity 363 371 2426 2434 O
with 372 376 2435 2439 O
a 377 378 2440 2441 O
partner 379 386 2442 2449 O
who 387 390 2450 2453 O
had 391 394 2454 2457 O
a 395 396 2458 2459 O
vasectomy 397 406 2460 2469 B-treatment

Women 0 5 2470 2475 B-gender
in 6 8 2476 2478 O
the 9 12 2479 2482 O
vaccine 13 20 2483 2490 B-treatment
- 20 21 2490 2491 O
eligible 21 29 2491 2499 O
age 30 33 2500 2503 B-age
range 34 39 2504 2509 O
can 40 43 2510 2513 O
not 43 46 2513 2516 O
have 47 51 2517 2521 O
received 52 60 2522 2530 O
vaccine 61 68 2531 2538 O
prior 69 74 2539 2544 O
to 75 77 2545 2547 O
enrollment 78 88 2548 2558 O
, 88 89 2558 2559 O
but 90 93 2560 2563 O
will 94 98 2564 2568 O
be 99 101 2569 2571 O
offered 102 109 2572 2579 O
HPV 110 113 2580 2583 B-treatment
vaccination 114 125 2584 2595 I-treatment
at 126 128 2596 2598 O
the 129 132 2599 2602 O
end 133 136 2603 2606 O
of 137 139 2607 2609 O
the 140 143 2610 2613 O
study 144 149 2614 2619 O
; 149 150 2619 2620 O
in 151 153 2621 2623 O
brief 154 159 2624 2629 O
, 159 160 2629 2630 O
we 161 163 2631 2633 O
are 164 167 2634 2637 O
interested 168 178 2638 2648 O
in 179 181 2649 2651 O
the 182 185 2652 2655 O
efficacy 186 194 2656 2664 O
of 195 197 2665 2667 O
intervention 198 210 2668 2680 O
in 211 213 2681 2683 O
preventing 214 224 2684 2694 O
HPV 225 228 2695 2698 O
in 229 231 2699 2701 O
the 232 235 2702 2705 O
absence 236 243 2706 2713 O
of 244 246 2714 2716 O
HPV 247 250 2717 2720 O
vaccination 251 262 2721 2732 O
, 262 263 2732 2733 O
since 264 269 2734 2739 O
most 270 274 2740 2744 O
women 275 280 2745 2750 B-gender
worldwide 281 290 2751 2760 O
who 291 294 2761 2764 O
might 295 300 2765 2770 O
utilize 301 308 2771 2778 O
intervention 309 321 2779 2791 O
will 322 326 2792 2796 O
not 327 330 2797 2800 O
have 331 335 2801 2805 O
been 336 340 2806 2810 O
vaccinated 341 351 2811 2821 B-treatment
; 351 352 2821 2822 O
this 353 357 2823 2827 O
includes 358 366 2828 2836 O
United 367 373 2837 2843 O
States 374 380 2844 2850 O
( 381 382 2851 2852 O
US 382 384 2852 2854 O
) 384 385 2854 2855 O
women 386 391 2856 2861 O
in 392 394 2862 2864 O
the 395 398 2865 2868 O
vaccine 399 406 2869 2876 O
catch 407 412 2877 2882 O
- 412 413 2882 2883 O
up 413 415 2883 2885 O
19 416 418 2886 2888 B-lower_bound
- 418 419 2888 2889 O
26 419 421 2889 2891 B-upper_bound
year 422 426 2892 2896 I-upper_bound
old 427 430 2897 2900 O
age 431 434 2901 2904 O
group 435 440 2905 2910 O
( 441 442 2911 2912 O
beyond 442 448 2912 2918 O
the 449 452 2919 2922 O
age 453 456 2923 2926 O
groups 457 463 2927 2933 O
eligible 464 472 2934 2942 O
for 473 476 2943 2946 O
Vaccines 477 485 2947 2955 B-treatment
for 486 489 2956 2959 O
Children- 490 499 2960 2969 O
funded 500 506 2970 2976 O
vaccination 507 518 2977 2988 O
) 518 519 2988 2989 O
who 520 523 2990 2993 O
have 524 528 2994 2998 O
so 529 531 2999 3001 O
far 532 535 3002 3005 O
had 536 539 3006 3009 O
very 540 544 3010 3014 O
low 545 548 3015 3018 O
( 549 550 3019 3020 O
< 550 551 3020 3021 O
10 552 554 3022 3024 B-upper_bound
% 554 555 3024 3025 I-upper_bound
) 555 556 3025 3026 O
vaccine 557 564 3027 3034 O
uptake 565 571 3035 3041 O
; 571 572 3041 3042 O
it 573 575 3043 3045 O
also 576 580 3046 3050 O
includes 581 589 3051 3059 O
the 590 593 3060 3063 O
entire 594 600 3064 3070 O
group 601 606 3071 3076 O
of 607 609 3077 3079 O
US 610 612 3080 3082 O
women 613 618 3083 3088 O
> 619 620 3089 3090 O
26 621 623 3091 3093 O
years 624 629 3094 3099 O
of 630 632 3100 3102 O
age 633 636 3103 3106 O
; 636 637 3106 3107 O
moreover 638 646 3108 3116 O
, 646 647 3116 3117 O
it 648 650 3118 3120 O
includes 651 659 3121 3129 O
women 660 665 3130 3135 O
of 666 668 3136 3138 O
all 669 672 3139 3142 O
ages 673 677 3143 3147 B-age
in 678 680 3148 3150 O
developing 681 691 3151 3161 O
countries 692 701 3162 3171 O
, 701 702 3171 3172 O
who 703 706 3173 3176 O
most 707 711 3177 3181 O
need 712 716 3182 3186 O
an 717 719 3187 3189 O
HPV 720 723 3190 3193 O
prevention 724 734 3194 3204 O
strategy 735 743 3205 3213 O
, 743 744 3213 3214 O
but 745 748 3215 3218 O
may 749 752 3219 3222 O
never 753 758 3223 3228 O
be 759 761 3229 3231 O
vaccinated 762 772 3232 3242 O
; 772 773 3242 3243 O
it 774 776 3244 3246 O
should 777 783 3247 3253 O
be 784 786 3254 3256 O
noted 787 792 3257 3262 O
that 793 797 3263 3267 O
delaying 798 806 3268 3276 O
vaccination 807 818 3277 3288 O
in 819 821 3289 3291 O
women 822 827 3292 3297 O
19 828 830 3298 3300 O
- 830 831 3300 3301 O
26 831 833 3301 3303 O
years 834 839 3304 3309 O
of 840 842 3310 3312 O
age 843 846 3313 3316 O
by 847 849 3317 3319 O
one 850 853 3320 3323 O
year 854 858 3324 3328 O
is 859 861 3329 3331 O
safe 862 866 3332 3336 O
and 867 870 3337 3340 O
reasonable 871 881 3341 3351 O
, 881 882 3351 3352 O
since 883 888 3353 3358 O
there 889 894 3359 3364 O
is 895 897 3365 3367 O
insufficient 898 910 3368 3380 O
data 911 915 3381 3385 O
to 916 918 3386 3388 O
establish 919 928 3389 3398 O
a 929 930 3399 3400 O
recommendation 931 945 3401 3415 O
for 946 949 3416 3419 O
or 950 952 3420 3422 O
against 953 960 3423 3430 O
universal 961 970 3431 3440 O
vaccination 971 982 3441 3452 O
in 983 985 3453 3455 O
this 986 990 3456 3460 O
age 991 994 3461 3464 O
group 995 1000 3465 3470 O
as 1001 1003 3471 3473 O
concluded 1004 1013 3474 3483 O
by 1014 1016 3484 3486 O
an 1017 1019 3487 3489 O
American 1020 1028 3490 3498 O
Cancer 1029 1035 3499 3505 O
Society 1036 1043 3506 3513 O
expert 1044 1050 3514 3520 O
panel 1051 1056 3521 3526 O
, 1056 1057 3526 3527 O
which 1058 1063 3528 3533 O
includes 1064 1072 3534 3542 O
the 1073 1076 3543 3546 O
Principal 1077 1086 3547 3556 O
Investigator 1087 1099 3557 3569 O
( 1100 1101 3570 3571 O
PI 1101 1103 3571 3573 O
) 1103 1104 3573 3574 O
of 1105 1107 3575 3577 O
this 1108 1112 3578 3582 O
protocol 1113 1121 3583 3591 O
, 1121 1122 3591 3592 O
Dr. 1123 1126 3593 3596 O
Mark 1127 1131 3597 3601 O
Einstein 1132 1140 3602 3610 O
; 1140 1141 3610 3611 O
it 1142 1144 3612 3614 O
is 1145 1147 3615 3617 O
anticipated 1148 1159 3618 3629 O
that 1160 1164 3630 3634 O
if 1165 1167 3635 3637 O
the 1168 1171 3638 3641 O
intervention 1172 1184 3642 3654 O
gel 1185 1188 3655 3658 O
is 1189 1191 3659 3661 O
efficacious 1192 1203 3662 3673 O
, 1203 1204 3673 3674 O
HPV 1205 1208 3675 3678 O
vaccinated 1209 1219 3679 3689 O
women 1220 1225 3690 3695 O
would 1226 1231 3696 3701 O
need 1232 1236 3702 3706 O
to 1237 1239 3707 3709 O
be 1240 1242 3710 3712 O
studied 1243 1250 3713 3720 O
in 1251 1253 3721 3723 O
a 1254 1255 3724 3725 O
similar 1256 1263 3726 3733 O
future 1264 1270 3734 3740 O
trial 1271 1276 3741 3746 O
with 1277 1281 3747 3751 O
power 1282 1287 3752 3757 O
analysis 1288 1296 3758 3766 O
taking 1297 1303 3767 3773 O
into 1304 1308 3774 3778 O
account 1309 1316 3779 3786 O
vaccine 1317 1324 3787 3794 O
effectiveness 1325 1338 3795 3808 O
as 1339 1341 3809 3811 O
well 1342 1346 3812 3816 O

